Form 4 filed by Duncan Jason
Duncan Jason filed this Form 4 on enGene Therapeutics Inc. with 1 transaction row and 0 holding rows, accepted by EDGAR 2026-11-13 21:54:00 UTC.
- Accession
- 0001552781-26-000553
- Filer
- CIK 1741553
- Filed
- 2026-11-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: enGene Therapeutics Inc. (CIK 1980845)
- Duncan Jason officer (Chief Legal & Admin Officer)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) derivative | 2026-11-13 | A granted | +500,000 | $0 | 500,000 | D |